NEW YORK (GenomeWeb News) – WaferGen Biosystems today reported that its third-quarter revenues rose sharply to $197,951 from $6,700 year over year.
 
The Fremont, Calif.-based firm posted a net loss of $2.1 million, or $.08 per share, for the three-month period ended Sept. 30, up 24 percent from a net loss of $1.7 million, or $.07 per share, for the third quarter of 2007.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.